144 related articles for article (PubMed ID: 26147886)
1. Implication of Leptin-Signaling Proteins and Epstein-Barr Virus in Gastric Carcinomas.
Choi E; Byeon SJ; Kim SH; Lee HJ; Kwon HJ; Ahn H; Kim DH; Chang MS
PLoS One; 2015; 10(7):e0130839. PubMed ID: 26147886
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.
Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS
Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.
Sukawa Y; Yamamoto H; Nosho K; Kunimoto H; Suzuki H; Adachi Y; Nakazawa M; Nobuoka T; Kawayama M; Mikami M; Matsuno T; Hasegawa T; Hirata K; Imai K; Shinomura Y
World J Gastroenterol; 2012 Dec; 18(45):6577-86. PubMed ID: 23236232
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea.
Chang MS; Lee HS; Kim CW; Kim YI; Kim WH
Pathol Res Pract; 2001; 197(6):395-400. PubMed ID: 11432666
[TBL] [Abstract][Full Text] [Related]
5. Role and prognostic significance of proapoptotic proteins in Epstein-Barr virus-infected gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Anticancer Res; 2007; 27(2):785-91. PubMed ID: 17465203
[TBL] [Abstract][Full Text] [Related]
6. Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with epstein-barr virus-negative carcinoma.
Lee HS; Chang MS; Yang HK; Lee BL; Kim WH
Clin Cancer Res; 2004 Mar; 10(5):1698-705. PubMed ID: 15014022
[TBL] [Abstract][Full Text] [Related]
7. Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
Huang SC; Ng KF; Yeh TS; Cheng CT; Lin JS; Liu YJ; Chuang HC; Chen TC
Int J Cancer; 2019 Dec; 145(12):3218-3230. PubMed ID: 30771224
[TBL] [Abstract][Full Text] [Related]
8. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
9. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement.
van Beek J; zur Hausen A; Klein Kranenbarg E; van de Velde CJ; Middeldorp JM; van den Brule AJ; Meijer CJ; Bloemena E
J Clin Oncol; 2004 Feb; 22(4):664-70. PubMed ID: 14966089
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Epstein-Barr virus involvement in gastric carcinoma in Japan.
Koriyama C; Akiba S; Itoh T; Kijima Y; Sueyoshi K; Corvalan A; Herrera-Goepfer R; Eizuru Y
Int J Mol Med; 2002 Nov; 10(5):635-9. PubMed ID: 12373307
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.
Carrascal E; Koriyama C; Akiba S; Tamayo O; Itoh T; Eizuru Y; Garcia F; Sera M; Carrasquilla G; Piazuelo MB; Florez L; Bravo JC
Oncol Rep; 2003; 10(4):1059-62. PubMed ID: 12792770
[TBL] [Abstract][Full Text] [Related]
12. Low rate of apoptosis and overexpression of bcl-2 in Epstein-Barr virus-associated gastric carcinoma.
Kume T; Oshima K; Shinohara T; Takeo H; Yamashita Y; Shirakusa T; Kikuchi M
Histopathology; 1999 Jun; 34(6):502-9. PubMed ID: 10383694
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis.
Chang MS; Lee HS; Kim HS; Kim SH; Choi SI; Lee BL; Kim CW; Kim YI; Yang M; Kim WH
J Pathol; 2003 Apr; 199(4):447-52. PubMed ID: 12635135
[TBL] [Abstract][Full Text] [Related]
14. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
[TBL] [Abstract][Full Text] [Related]
15. Low density of CD204-positive M2-type tumor-associated macrophages in Epstein-Barr virus-associated gastric cancer: a clinicopathologic study with digital image analysis.
Ichimura T; Abe H; Morikawa T; Yamashita H; Ishikawa S; Ushiku T; Seto Y; Fukayama M
Hum Pathol; 2016 Oct; 56():74-80. PubMed ID: 27342912
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus and gastric carcinoma in Western patients: comparison of pathological parameters and p53 expression in EBV-positive and negative tumours.
Chapel F; Fabiani B; Davi F; Raphael M; Tepper M; Champault G; Guettier C
Histopathology; 2000 Mar; 36(3):252-61. PubMed ID: 10692029
[TBL] [Abstract][Full Text] [Related]
17. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.
Kim J; Lee HS; Bae SI; Lee YM; Kim WH
Anticancer Res; 2005; 25(6B):4013-9. PubMed ID: 16309193
[TBL] [Abstract][Full Text] [Related]
18. Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.
Roh CK; Choi YY; Choi S; Seo WJ; Cho M; Jang E; Son T; Kim HI; Kim H; Hyung WJ; Huh YM; Noh SH; Cheong JH
Yonsei Med J; 2019 Feb; 60(2):132-139. PubMed ID: 30666834
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Tunisia.
Trimeche M; Ksiâa F; Ziadi S; Mestiri S; Hachana M; Gacem RB; Sriha B; Korbi S
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1001-7. PubMed ID: 19491698
[TBL] [Abstract][Full Text] [Related]
20. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
